{"category":{"kind":"industry","slug":"biotechnology","name":"Biotechnology","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T05:51:04.133Z","updated_at":"2026-09-03T05:51:04.133Z","example":false,"profile_url":"/industries/biotechnology","is_stub":true,"member_count":22,"member_counts":{"company":22}},"members":[{"listing_type":"company","name":"Anacalypsis Therapeutics","slug":"anacalypsis-therapeutics","tagline":"Precision therapeutics and biomarkers for Parkinson’s disease","description":"Anacalypsis Therapeutics is a Greek biotech developing disease-modifying treatments and early biomarkers for neurodegenerative diseases, with a focus on Parkinson’s disease. The company applies genetically linked targets and structure-based design to interfere with protein interactions and signaling pathways associated with neurodegeneration, and operates from the Athens LifeTech Park area.","url":"https://anacalypsistherapeutics.com/","is_stealth":false,"normalized_domain":"anacalypsistherapeutics.com","normalized_url_key":"anacalypsistherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://anacalypsistherapeutics.com/wp-content/uploads/2023/05/cropped-Capture-1.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/anacalypsis-therapeutics","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://anacalypsistherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://anacalypsistherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Alexia V. Polissidis","role":"CEO and Co-Founder","person_slug":"alexia-v-polissidis-2jdxjdf07nd8m","bio":null,"location":null,"links":[]},{"name":"Hardy J. Rideout","role":"CSO and Co-Founder","person_slug":"hardy-j-rideout-2b8sif97b5men","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"d0369378-94fa-4abb-8cc3-a8da3238bd6d"},"categories":["Biotechnology","Neuroscience","Health"],"stage":"pre-seed","founded_year":null,"location":"Athens, Greece","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/anacalypsis-therapeutics","contact_email":null,"added_at":"2026-09-21T14:50:46.627Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-21T14:50:46.627Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"health","name":"Health","note":null,"profile_url":"/industries/health"},{"kind":"industry","slug":"neuroscience","name":"Neuroscience","note":null,"profile_url":"/industries/neuroscience"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-21T14:50:46.627Z","updated_at":"2026-09-21T14:50:46.627Z"}},{"listing_type":"company","name":"Novadip Biosciences","slug":"novadip-biosciences","tagline":"Tissue regenerative medicine for severe bone defects","description":"Novadip Biosciences is a Belgian biotech developing regenerative therapies to repair severe bone defects. Its lead program NVD003 is an autologous cell-based therapy for congenital pseudarthrosis of the tibia and is in a pivotal Phase 3 study in the United States and Europe.","url":"https://novadip.com/","is_stealth":false,"normalized_domain":"novadip.com","normalized_url_key":"novadip.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://novadip.com/wp-content/uploads/2022/09/cropped-20200406-Novadip-Logo-vertical-270x270.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/novadip-biosciences-s-a-","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://novadip.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://novadip.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"8895ac2f-223e-4b69-82d6-efdf8c8470d4"},"categories":["Biotechnology","Regenerative Medicine","Health"],"stage":null,"founded_year":null,"location":"Louvain-la-Neuve, Belgium","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/novadip-biosciences-s-a-","contact_email":null,"added_at":"2026-09-21T14:50:17.463Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-21T14:50:17.463Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"health","name":"Health","note":null,"profile_url":"/industries/health"},{"kind":"industry","slug":"regenerative-medicine","name":"Regenerative Medicine","note":null,"profile_url":"/industries/regenerative-medicine"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-21T14:50:17.463Z","updated_at":"2026-09-21T14:50:17.463Z"}},{"listing_type":"company","name":"Osmo","slug":"osmo","tagline":"AI olfactory technology that teaches computers to read, write, and map scent","description":"Osmo is an olfactory technology company combining AI, neuroscience, and perfumery expertise to digitize smell and reimagine fragrance development, creation, and end-to-end manufacturing. Spun out of Google Brain work and founded in 2022, Osmo partners with brands to design and launch fragrances using what it calls Olfactory Intelligence (OI). Public materials emphasize custom fragrance development with rapid iteration and compliant ingredients.","url":"https://www.osmo.ai/","is_stealth":false,"normalized_domain":"osmo.ai","normalized_url_key":"osmo.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.prod.website-files.com/69d56de91b59477a7776fadd/69dded0d1c5733ce4dd4a8df_Favicon.png","links":[{"label":"X / Twitter","url":"https://x.com/Osmo_Labs","platform":"x"},{"label":"LinkedIn","url":"https://www.linkedin.com/company/osmolabs/","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://www.osmo.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.osmo.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"b12387da-0f31-4b39-80f5-79c0f0deb7bd"},"categories":["AI","Consumer","Deep Tech","Biotechnology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":"https://x.com/Osmo_Labs","github":null,"linkedin":"https://www.linkedin.com/company/osmolabs/","contact_email":null,"added_at":"2026-09-20T08:18:46.740Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-20T14:09:36.684Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"consumer","name":"Consumer","note":null,"profile_url":"/industries/consumer"},{"kind":"industry","slug":"deep-tech","name":"Deep Tech","note":null,"profile_url":"/industries/deep-tech"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-20T08:18:46.740Z","updated_at":"2026-09-20T08:18:46.740Z"}},{"listing_type":"company","name":"ReEmerge","slug":"reemerge","tagline":"MedTech developing Cognitive Network Restoration Therapy for chronic cognitive impairment after brain injury","description":"ReEmerge is a private MedTech company developing Cognitive Network Restoration Therapy (CNRT), an investigational approach that targets neural networks disrupted by brain injury. The company exited stealth in September 2026 and is preparing clinical evaluation of CNRT for traumatic brain injury. CNRT is limited by U.S. federal law to investigational use and is not approved for commercial use.","url":"https://www.reemergeinc.com/","is_stealth":false,"normalized_domain":"reemergeinc.com","normalized_url_key":"reemergeinc.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.prod.website-files.com/6a99ae3c3e94b858286907f6/6aa17d66aa58adc55b32c44a_favicon-dots-512%402x.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/reemerge-inc","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://www.reemergeinc.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.reemergeinc.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Todd Langevin","role":"Chief Executive Officer","person_slug":"todd-langevin-29meahgqbxzvu","bio":null,"location":null,"links":[]},{"name":"Nicholas Schiff, MD","role":"Scientific Co-Founder","person_slug":"nicholas-schiff-md-1f6fwoeoytjwa","bio":null,"location":null,"links":[]},{"name":"Jaimie Henderson, MD","role":"Scientific Co-Founder","person_slug":"jaimie-henderson-md-2ptqy46k9phbt","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"064bbf10-0106-493e-81fa-2b37cdd45866"},"categories":["Healthtech","MedTech","Biotechnology","Healthcare"],"stage":"series-a","founded_year":null,"location":"Edina, Minnesota, USA","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/reemerge-inc","contact_email":null,"added_at":"2026-09-16T11:19:23.224Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-16T11:19:23.224Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"healthtech","name":"HealthTech","note":null,"profile_url":"/industries/healthtech"},{"kind":"industry","slug":"medtech","name":"MedTech","note":null,"profile_url":"/industries/medtech"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-16T11:19:23.224Z","updated_at":"2026-09-16T11:19:23.224Z"}},{"listing_type":"company","name":"Creative Biogene","slug":"creativebiogene","tagline":"Creative Biogene","description":"As a scientists-founded and scientists-driven leading biotechnological company, Creative Biogene focuses on developing high quality products and services, as well as proprietary technology to support the research in the field of basic life sciences research, biomedical development, industrial synthetic application and preclinical drug discovery.","url":"https://www.creative-biogene.com/","is_stealth":false,"normalized_domain":"creative-biogene.com","normalized_url_key":"creative-biogene.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.creative-biogene.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.creative-biogene.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"3e993edd-6407-45d4-942b-48105ed81e68","cover_asset_id":null,"screenshot_asset_ids":[]},"categories":["biotechnology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":"contact@creative-biogene.com","added_at":"2026-09-16T05:46:43.418Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-16T05:46:43.418Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-16T05:46:43.418Z","updated_at":"2026-09-16T05:46:43.418Z"}},{"listing_type":"company","name":"Creative Bioarray","slug":"creativebioarray","tagline":"biotechnology","description":"Creative Bioarray is an innovative biotechnology company whose mission focuses on developing unique technologies that provide global scientists with high quality products and satisfactory services to facilitate the investigation of life science researches.","url":"https://www.creative-bioarray.com/","is_stealth":false,"normalized_domain":"creative-bioarray.com","normalized_url_key":"creative-bioarray.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.creative-bioarray.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.creative-bioarray.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":null,"cover_asset_id":null,"screenshot_asset_ids":["09e34a09-5f7d-42d8-8dce-3e7ea5add23a"]},"categories":["biotechnology"],"stage":null,"founded_year":null,"location":"Shirley, NY 11967, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":"contact@creative-bioarray.com","added_at":"2026-09-16T05:43:41.040Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-16T05:43:41.040Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-16T05:43:41.040Z","updated_at":"2026-09-16T05:43:41.040Z"}},{"listing_type":"company","name":"TareBio","slug":"tarebio","tagline":"Vaccines for any cancer or infection in weeks.","description":"Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.\n\nTareBio is a Y Combinator company (Summer 2026). YC-listed status: Active.","url":"https://tarebio.com/","is_stealth":false,"normalized_domain":"tarebio.com","normalized_url_key":"tarebio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/9e770bbea41518001119968d389d0d3e35ce7abe.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/tarebio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://tarebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://tarebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Vaccines","Synthetic Biology","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:32:26.489Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2026","Vaccines","Synthetic Biology","Biotechnology"],"one_liner_for_search":"TareBio — Vaccines for any cancer or infection in weeks. (Y Combinator Summer 2026)","canonical_facts":["Y Combinator batch: Summer 2026","YC company status: Active","Team size (per YC directory): 1","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:32:26.489Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"vaccines","name":"Vaccines","note":null,"profile_url":"/industries/vaccines"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:32:26.489Z","updated_at":"2026-09-03T08:32:26.489Z"}},{"listing_type":"company","name":"Atlas Discovery","slug":"atlas-discovery","tagline":"AI-native pharma company","description":"AI-native pharma company\n\nAtlas Discovery is a Y Combinator company (Summer 2026). YC-listed status: Active.","url":"https://atlasdiscovery.bio/","is_stealth":false,"normalized_domain":"atlasdiscovery.bio","normalized_url_key":"atlasdiscovery.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6e6c174c3a8e56844bf81efbc8b8532b4e509f73.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/atlas-discovery","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://atlasdiscovery.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://atlasdiscovery.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","AI-powered Drug Discovery","Drug discovery","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:28:33.118Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2026","AI-powered Drug Discovery","Drug discovery","Biotechnology"],"one_liner_for_search":"Atlas Discovery — AI-native pharma company (Y Combinator Summer 2026)","canonical_facts":["Y Combinator batch: Summer 2026","YC company status: Active","Team size (per YC directory): 3","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Rhizome Bio","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:28:33.118Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:28:33.118Z","updated_at":"2026-09-03T08:28:33.118Z"}},{"listing_type":"company","name":"Ritivel","slug":"ritivel","tagline":"AI-native platform for Life-Sciences Documentation","description":"Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster.\n\nEvery month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions.\n\nRitivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FDA formatting requirements and pulling from your existing clinical data and prior submissions. Every data point includes citations linked back to the original source, so reviewers can verify with one click. Connected to SharePoint and Veeva, our agents automatically source the right documents. Integrated with Outlook, they handle reminder emails and follow-ups automatically.\n\nWe're engineers who previously built AI copilots at Microsoft Research. After 50+ conversations with pharma professionals, we discovered the critical bottleneck in regulatory submissions and built Ritivel to solve it.\n\nRitivel is a Y Combinator company (Winter 2026). YC-listed status: Active.","url":"https://www.ritivel.com/","is_stealth":false,"normalized_domain":"ritivel.com","normalized_url_key":"ritivel.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/20339e5cb76cdfb65db692fb1ab38e8c6f710609.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/ritivel","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.ritivel.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.ritivel.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Healthcare IT","Generative AI","Compliance","Enterprise Software","Regtech","Biotechnology"],"stage":null,"founded_year":null,"location":"Bengaluru, KA, India","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:23:14.769Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2026","Generative AI","Compliance","Enterprise Software","Regtech","Biotechnology"],"one_liner_for_search":"Ritivel — AI-native platform for Life-Sciences Documentation (Y Combinator Winter 2026)","canonical_facts":["Y Combinator batch: Winter 2026","YC company status: Active","Team size (per YC directory): 3","YC industry: Healthcare","YC subindustry: Healthcare / Healthcare IT","Former names: Ritivel, ritivel","Regions (per YC): India, South Asia"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:23:14.769Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"compliance","name":"Compliance","note":null,"profile_url":"/industries/compliance"},{"kind":"industry","slug":"enterprise-software","name":"Enterprise Software","note":null,"profile_url":"/industries/enterprise-software"},{"kind":"industry","slug":"generative-ai","name":"Generative AI","note":null,"profile_url":"/industries/generative-ai"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"healthcare-it","name":"Healthcare IT","note":null,"profile_url":"/industries/healthcare-it"},{"kind":"industry","slug":"regtech","name":"RegTech","note":null,"profile_url":"/industries/regtech"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:23:14.769Z","updated_at":"2026-09-03T08:23:14.769Z"}},{"listing_type":"company","name":"Scoop","slug":"scoop","tagline":"Automating regulatory submissions for life sciences","description":"We’re building AI agents that speed up drug trials by automating the manual consolidation and document prep required for every IND submission. Today, biotechs spend months stitching together reports from contractors and internal teams just to file and get to their first-in-human trial.\n\nScoop is a Y Combinator company (Fall 2025). YC-listed status: Active.","url":"https://scooplabs.ai/","is_stealth":false,"normalized_domain":"scooplabs.ai","normalized_url_key":"scooplabs.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/70fc9c8245a9de2b245841faf07e0530dd3f51a1.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/scoop","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://scooplabs.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://scooplabs.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["B2B","Artificial Intelligence","Biotech","Compliance","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:14:16.373Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Fall 2025","Artificial Intelligence","B2B","Biotech","Compliance","Biotechnology"],"one_liner_for_search":"Scoop — Automating regulatory submissions for life sciences (Y Combinator Fall 2025)","canonical_facts":["Y Combinator batch: Fall 2025","YC company status: Active","Team size (per YC directory): 2","YC industry: B2B","YC subindustry: B2B","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:14:16.373Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"b2b","name":"B2B","note":null,"profile_url":"/industries/b2b"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"compliance","name":"Compliance","note":null,"profile_url":"/industries/compliance"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:14:16.373Z","updated_at":"2026-09-03T08:14:16.373Z"}},{"listing_type":"company","name":"Nexa Labs","slug":"nexa-labs","tagline":"Implantable microchips and AI for cattle monitoring","description":"Nexa is developing the solution for cattle monitoring, leveraging implantable microchips that collect more comprehensive biometrics than anything else on the market. Our accompanying AI-driven animal health engine empowers farmers with early disease detection, reproductive insights, GPS tracking, and more. \n\nWe're saving farmers time and money while collecting the world's largest cattle health dataset. We believe that cattle farming should be a science, not an art - this will secure the world's food supply and increase economic output that billions of people depend on.\n\nNexa Labs is a Y Combinator company (Summer 2025). YC-listed status: Acquired.","url":"https://nexa.farm/","is_stealth":false,"normalized_domain":"nexa.farm","normalized_url_key":"nexa.farm","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/489fd97ad45ee1d6d874c7a99792bf1552ebddc2.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/nexa-labs","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://nexa.farm/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nexa.farm/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Agriculture","Livestock Health","Medical Devices","AI","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:10:06.857Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2025","Livestock Health","Medical Devices","Agriculture","AI","Biotechnology"],"one_liner_for_search":"Nexa Labs — Implantable microchips and AI for cattle monitoring (Y Combinator Summer 2025)","canonical_facts":["Y Combinator batch: Summer 2025","YC company status: Acquired","Team size (per YC directory): 3","YC industry: Industrials","YC subindustry: Industrials / Agriculture","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:10:06.857Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"livestock-health","name":"Livestock Health","note":null,"profile_url":"/industries/livestock-health"},{"kind":"industry","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/industries/medical-devices"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:10:06.857Z","updated_at":"2026-09-03T08:10:06.857Z"}},{"listing_type":"company","name":"Uncommon Therapeutics","slug":"uncommon-therapeutics","tagline":"A Disease Focused Biotech, Building Multiple Billion Dollar Drugs","description":"Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.\n\nUncommon Therapeutics is a Y Combinator company (Winter 2025). YC-listed status: Active.","url":"https://www.uncommontherapeutics.com/","is_stealth":false,"normalized_domain":"uncommontherapeutics.com","normalized_url_key":"uncommontherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/791a2a1e71f62bafa47311d3711d9cab4712eea4.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/uncommon-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","CRISPR","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:54:06.858Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2025","Gene Therapy","CRISPR","Biotechnology"],"one_liner_for_search":"Uncommon Therapeutics — A Disease Focused Biotech, Building Multiple Billion Dollar Drugs (Y Combinator Winter 2025)","canonical_facts":["Y Combinator batch: Winter 2025","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:54:06.858Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/industries/crispr"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:54:06.858Z","updated_at":"2026-09-03T07:54:06.858Z"}},{"listing_type":"company","name":"Evolvere BioSciences","slug":"evolvere-biosciences","tagline":"Making Next-Generation Antibiotics that Outpace Bacterial Evolution","description":"🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. \n\n☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. \n\n🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️.\n\nWe are a team of biochemists and evolutionary biologists who met at the University of Oxford.\n\nEvolvere BioSciences is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://evolverebiosciences.com/","is_stealth":false,"normalized_domain":"evolverebiosciences.com","normalized_url_key":"evolverebiosciences.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/dd3489b7e5a5f2d3f7cc49de65917a83134da0a3.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/evolvere-biosciences","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://evolverebiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://evolverebiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","AI-powered Drug Discovery","Artificial Intelligence","Biotech","Biotechnology"],"stage":null,"founded_year":null,"location":"Oxford, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:44:24.123Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","AI-powered Drug Discovery","Artificial Intelligence","Biotech","Therapeutics","Biotechnology"],"one_liner_for_search":"Evolvere BioSciences — Making Next-Generation Antibiotics that Outpace Bacterial Evolution (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 3","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United Kingdom, Europe"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:44:24.123Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:44:24.123Z","updated_at":"2026-09-03T07:44:24.123Z"}},{"listing_type":"company","name":"Eugit Therapeutics","slug":"eugit-therapeutics","tagline":"Enabling Tissue Targeting of Therapies","description":"Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years.\n\nCofounded by George Church (Harvard) and funded by Y Combinator (S22).\n\nEugit Therapeutics is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.eugittx.com/","is_stealth":false,"normalized_domain":"eugittx.com","normalized_url_key":"eugittx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/a88b74cc086730f852f068c605f2dcaa54b40a16.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/eugit-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Cell Therapy","Synthetic Biology","Oncology","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; South San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:11:22.895Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","Cell Therapy","Synthetic Biology","Therapeutics","Oncology","Biotechnology"],"one_liner_for_search":"Eugit Therapeutics — Enabling Tissue Targeting of Therapies (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: EUGIT Tx, EUGIT Therapeutics, Eugit, Eugit Therapeutics Inc","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:11:22.895Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:11:22.895Z","updated_at":"2026-09-03T07:11:22.895Z"}},{"listing_type":"company","name":"Alixia","slug":"alixia","tagline":"Targeting the Tumor Ecosystem to address cancer drug resistance.","description":"Our compounds disrupt the metabolic and\ninflammatory triggers in both cancer and quasi-cancerous\ncells in the tumor microenvironment. By impacting multiple cell\ntypes, we are enabling effective, lasting cancer treatments.\n\nAlixia is a Y Combinator company (Winter 2022). YC-listed status: Active.","url":"https://www.alixia.com/","is_stealth":false,"normalized_domain":"alixia.com","normalized_url_key":"alixia.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ff4093c59629c7638e73b36eb069911e0922c140.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/alixia","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Drug discovery","Oncology","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:03:09.927Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2022","Biotech","Therapeutics","Drug discovery","Oncology","Biotechnology"],"one_liner_for_search":"Alixia — Targeting the Tumor Ecosystem to address cancer drug resistance. (Y Combinator Winter 2022)","canonical_facts":["Y Combinator batch: Winter 2022","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Guided Clarity","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:03:09.927Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:03:09.927Z","updated_at":"2026-09-03T07:03:09.927Z"}},{"listing_type":"company","name":"SFA Therapeutics","slug":"sfa-therapeutics-inc","tagline":"Regulating the immune system to block cancer & autoimmune diseases","description":"SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.\n\nSFA Therapeutics is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://sfatherapeutics.com/","is_stealth":false,"normalized_domain":"sfatherapeutics.com","normalized_url_key":"sfatherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/5873834b208e59808a81e6f7b65403be4dd9fc78.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/sfa-therapeutics-inc","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://sfatherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://sfatherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","AI-powered Drug Discovery","Anti-Aging","Biotech","Health & Wellness","Biotechnology"],"stage":null,"founded_year":null,"location":"Philadelphia, PA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:58:19.617Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","AI-powered Drug Discovery","Anti-Aging","Biotech","Health & Wellness","Biotechnology"],"one_liner_for_search":"SFA Therapeutics — Regulating the immune system to block cancer & autoimmune diseases (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: SFA Therapeutics, Inc.","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:58:19.617Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"anti-aging","name":"Anti-Aging","note":null,"profile_url":"/industries/anti-aging"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"health-and-wellness","name":"Health & Wellness","note":null,"profile_url":"/industries/health-and-wellness"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:58:19.617Z","updated_at":"2026-09-03T06:58:19.617Z"}},{"listing_type":"company","name":"Sensible Biotechnologies","slug":"sensible-biotechnologies","tagline":"Unlocking the next generation of mRNA medicines","description":"The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.\n\nSensible Biotechnologies is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://www.sensible.bio/","is_stealth":false,"normalized_domain":"sensible.bio","normalized_url_key":"sensible.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/45d14c57e3b4e2739c65c0bb84a511608548ffa2.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/sensible-biotechnologies","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.sensible.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.sensible.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Synthetic Biology","Biotech","Manufacturing","Biotechnology"],"stage":null,"founded_year":null,"location":"Oxford, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:58:03.441Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","Synthetic Biology","Biotech","Manufacturing","Therapeutics","Biotechnology"],"one_liner_for_search":"Sensible Biotechnologies — Unlocking the next generation of mRNA medicines (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 24","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Genbiotics","Regions (per YC): United Kingdom, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:58:03.441Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"manufacturing","name":"Manufacturing","note":null,"profile_url":"/industries/manufacturing"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:58:03.441Z","updated_at":"2026-09-03T06:58:03.441Z"}},{"listing_type":"company","name":"UrbanKisaan","slug":"urbankisaan","tagline":"Foundation models and autonomous chambers for plant biology","description":"UrbanKisaan is an AI-for-plant-biology company. We build foundation models and the physical infrastructure that trains them.\n\nShipping a single new seed variety takes about ten+ years. Two on germplasm, three on crosses and selection, three or four on field trials, one on regulatory. Inside that decade, prediction and experiment never properly meet. DNA is abundant, phenotype data is scarce and unpaired, and the cycle never trains itself.\n\nWe closed that loop.\n\nThree foundation models cover the upstream science. \n\nAadi is a 48-layer transformer trained from scratch on the public and proprietary corpus of plant genomes; it reads plant DNA and ranks variants before any wet-lab spend. \n\nJeeva is the genotype-to-phenotype model that turns a seed and a target environment into yield, flowering, maturity, and height with confidence intervals plus per-locus attribution. \n\nAkash is the geospatial backbone - it maps every pixel of every field to crop class and growing condition.\n\nTwo pieces of physical infrastructure close the downstream half. \n\nGeneRush is a controlled-environment chamber engineered for speed: extended photoperiod, optimized temperature, integrated phenomics. Wheat reaches anthesis in 38 days. Breeding programs run 4–6 generations a year instead of 1–2. \n\nGrowRush takes that same chamber to commercial production scale, where every harvest is also a labelled phenotype training pair flowing back to Jeeva. The unit is paid for by what it grows; the science works because the unit is identical to the chamber the AI was trained on.\n\nEvery cycle produces proprietary genotype-to-phenotype data the next generation of models needs. The ten-year breeding cycle compresses toward three. We are already commercial\n\nUrbanKisaan is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.urbankisaan.com/","is_stealth":false,"normalized_domain":"urbankisaan.com","normalized_url_key":"urbankisaan.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/46e8aa32e04a21d9a5ef18ccaae02b6b9ddea65d.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/urbankisaan","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.urbankisaan.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.urbankisaan.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Industrials","Agriculture","Biotech","AI","Sustainable Agriculture","Biotechnology"],"stage":null,"founded_year":null,"location":"Hyderabad, Telangana, India","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:30:28.961Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Biotech","Agriculture","AI","Sustainable Agriculture","Biotechnology"],"one_liner_for_search":"UrbanKisaan — Foundation models and autonomous chambers for plant biology (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 53","YC industry: Industrials","YC subindustry: Industrials / Agriculture","Regions (per YC): India, South Asia"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:30:28.961Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"industrials","name":"Industrials","note":null,"profile_url":"/industries/industrials"},{"kind":"industry","slug":"sustainable-agriculture","name":"Sustainable Agriculture","note":null,"profile_url":"/industries/sustainable-agriculture"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:30:28.961Z","updated_at":"2026-09-03T06:30:28.961Z"}},{"listing_type":"company","name":"Volta Labs, Inc.","slug":"volta-labs-inc","tagline":"Unlocking the utility of genomics for the world.","description":"Volta Labs is a genomics applications company that has developed a cutting-edge digital fluidics platform to maximize performance and scalability of sample preparation in genomics while providing unparalleled consistency. Volta is transforming the way biological research and analyses are performed, allowing scientists to focus on what they do best -- pushing the boundaries of biology.\n\nAs a collective of scientists and builders working at the intersection of engineering and biology, we imagine a world where extracting vital information from biological samples is as simple as pressing a button. That's our vision, and we're turning it into reality.\n\nOur HQ is in Boston’s Seaport, where we develop and manufacture our technology. We believe in cross-functional collaboration and continuous learning –  whether your interest is in biology, MechEng, CompEng, or simply joining a fast-growing startup striving to make the world a better place, we'd love to welcome you to our team. Check out some of our blog posts to learn more about work life at Volta.\n\nVolta Labs, Inc. is a Y Combinator company (Winter 2019). YC-listed status: Active.","url":"https://voltalabs.com/","is_stealth":false,"normalized_domain":"voltalabs.com","normalized_url_key":"voltalabs.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/373e91d473569c304899f7cec638ddc0b46d10d6.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/volta-labs-inc","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://voltalabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://voltalabs.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Hard Tech","Hardware","Robotics","Genomics","Biotechnology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA; Cambridge, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:20:28.268Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2019","Hard Tech","Hardware","Robotics","Genomics","Biotechnology"],"one_liner_for_search":"Volta Labs, Inc. — Unlocking the utility of genomics for the world. (Y Combinator Winter 2019)","canonical_facts":["Y Combinator batch: Winter 2019","YC company status: Active","Team size (per YC directory): 50","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: Volta Labs Inc.","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:20:28.268Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"hard-tech","name":"Hard Tech","note":null,"profile_url":"/industries/hard-tech"},{"kind":"industry","slug":"hardware","name":"Hardware","note":null,"profile_url":"/industries/hardware"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"robotics","name":"Robotics","note":null,"profile_url":"/industries/robotics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:20:28.268Z","updated_at":"2026-09-03T06:20:28.268Z"}},{"listing_type":"company","name":"Mytos","slug":"cytera-cellworks","tagline":"Robotic human cell manufacturing","description":"Mytos builds robots for manufacturing human cells. Operators input stem cells, and our platform turns them into specific cells such as neurons and heart cells over multiple weeks.\n\nLast year, patients were cured of Parkinson’s, vision loss, and Type 1 diabetes using stem-cell derived cells. We need 1000x the global capacity to produce these cells, and treat millions of patients. But today these Regenerative Medicines are produced by hand, meaning they’re too expensive and don’t scale.\n\nMytos has fully automated production of these cells, making it scalable. We have our first manufacturing deal - neurons for treating Parkinson’s - and we’re in conversations with majority of the other top players.\n\nMytos is a Y Combinator company (Summer 2018). YC-listed status: Active.","url":"https://www.mytos.bio/","is_stealth":false,"normalized_domain":"mytos.bio","normalized_url_key":"mytos.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/47b55852a1fff0b5b096b7decf0a07ed6cdb0636.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/cytera-cellworks","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.mytos.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.mytos.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Hardware","IoT","Biotech","Automation","Biotechnology"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:16:24.918Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2018","Hardware","IoT","Biotech","Automation","Biotechnology"],"one_liner_for_search":"Mytos — Robotic human cell manufacturing (Y Combinator Summer 2018)","canonical_facts":["Y Combinator batch: Summer 2018","YC company status: Active","Team size (per YC directory): 26","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: HackScience, Cytera CellWorks","Regions (per YC): United Kingdom, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:16:24.918Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"automation","name":"Automation","note":null,"profile_url":"/industries/automation"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"hardware","name":"Hardware","note":null,"profile_url":"/industries/hardware"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"iot","name":"IoT","note":null,"profile_url":"/industries/iot"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:16:24.918Z","updated_at":"2026-09-03T06:16:24.918Z"}},{"listing_type":"company","name":"Solugen","slug":"solugen","tagline":"Decarbonizing the chemicals industry.","description":"Solugen is decarbonizing the chemistry of everyday life with enzymes and innovative metal catalysts. Our new to the world Bioforge platform technology can produce high value chemical goods that are biobased and carbon negative, at cost on par with current technologies. We are making sustainable chemistry accessible to all living things, to ensure a prosperous world exists for generations.\n\nSolugen is a Y Combinator company (Winter 2017). YC-listed status: Active.","url":"https://solugen.com/","is_stealth":false,"normalized_domain":"solugen.com","normalized_url_key":"solugen.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/8d4235cadbab6a51a7bfa10e7b2877bdb12a26fe.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/solugen","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://solugen.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://solugen.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Industrial Bio","Manufacturing","Climate","ClimateTech","Biotechnology","Industrial"],"stage":null,"founded_year":null,"location":"Houston, TX, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:07:02.898Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2017","Manufacturing","Climate","ClimateTech","Biotechnology","Industrial"],"one_liner_for_search":"Solugen — Decarbonizing the chemicals industry. (Y Combinator Winter 2017)","canonical_facts":["Y Combinator batch: Winter 2017","YC company status: Active","Team size (per YC directory): 200","YC industry: Healthcare","YC subindustry: Healthcare / Industrial Bio","Former names: Solugen, Bioperoxide","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:07:02.898Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"climate","name":"Climate","note":null,"profile_url":"/industries/climate"},{"kind":"industry","slug":"climatetech","name":"ClimateTech","note":null,"profile_url":"/industries/climatetech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"industrial","name":"Industrial","note":null,"profile_url":"/industries/industrial"},{"kind":"industry","slug":"industrial-bio","name":"Industrial Bio","note":null,"profile_url":"/industries/industrial-bio"},{"kind":"industry","slug":"manufacturing","name":"Manufacturing","note":null,"profile_url":"/industries/manufacturing"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:07:02.898Z","updated_at":"2026-09-03T06:07:02.898Z"}},{"listing_type":"company","name":"TAXA Biotechnologies","slug":"taxa-biotechnologies","tagline":"We enable cheaper, faster, and better genetic engineering of plants.…","description":"The TAXA platform has been specifically designed to enable anyone to perform metabolic engineering of plants without stepping into a lab. We provide access to protein engineering, DNA assembly, transient experiments and stable transformation as a service. The best thing is that anything \"Powered by TAXA\" is designed to be free from expensive regulatory approval, meaning the products are available for sale or distribution to consumers in the United States immediately after they are developed. For a detailed list of the experiments which can be run on our platform please see the Services page.\n\nOur vision is a world where bio-engineering is as easy and commonplace as mobile application development is today. Game-changing technologies, like genetic engineering, should not be the exclusive preserve of large corporations and a wealthy elite. Democratizing the tools of creation enables anyone, anywhere, to genetically engineer plants and will unleash a wave of creativity to power an environment where ultimately what we create is limited only by our imagination.  The TAXA platform is our next step in the realization of that dream\n\nWe are also the team behind the first synthetic biology crowdfunding project, raising $484k on Kickstarter to make real glowing plants: www.glowingplant.com\n\nTAXA Biotechnologies is a Y Combinator company (Summer 2014). YC-listed status: Inactive.","url":"http://www.taxa.com/home/index.php","is_stealth":false,"normalized_domain":"taxa.com","normalized_url_key":"taxa.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/taxa-biotechnologies","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"http://www.taxa.com/home/index.php","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"http://www.taxa.com/home/index.php","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Consumer Health and Wellness","Agriculture","Genetic Engineering","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T05:51:04.133Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2014","Agriculture","Genetic Engineering","Biotechnology"],"one_liner_for_search":"TAXA Biotechnologies — We enable cheaper, faster, and better genetic engineering of plants.… (Y Combinator Summer 2014)","canonical_facts":["Y Combinator batch: Summer 2014","YC company status: Inactive","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Consumer Health and Wellness","Former names: Glowing Plant","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T05:51:04.133Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"agriculture","name":"Agriculture","note":null,"profile_url":"/industries/agriculture"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"consumer-health-and-wellness","name":"Consumer Health and Wellness","note":null,"profile_url":"/industries/consumer-health-and-wellness"},{"kind":"industry","slug":"genetic-engineering","name":"Genetic Engineering","note":null,"profile_url":"/industries/genetic-engineering"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T05:51:04.133Z","updated_at":"2026-09-03T05:51:04.133Z"}}],"total":22,"limit":50,"offset":0}